Kestra Private Wealth Services LLC Sells 1,465 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Kestra Private Wealth Services LLC reduced its stake in Teladoc Health, Inc. (NYSE:TDOC) by 9.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,641 shares of the health services provider’s stock after selling 1,465 shares during the period. Kestra Private Wealth Services LLC’s holdings in Teladoc Health were worth $316,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the stock. ARK Investment Management LLC increased its holdings in shares of Teladoc Health by 4.5% in the fourth quarter. ARK Investment Management LLC now owns 21,224,565 shares of the health services provider’s stock worth $457,389,000 after purchasing an additional 912,692 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Teladoc Health by 37.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,549,585 shares of the health services provider’s stock worth $28,807,000 after acquiring an additional 418,909 shares during the last quarter. International Assets Investment Management LLC raised its holdings in shares of Teladoc Health by 1,777.0% in the 4th quarter. International Assets Investment Management LLC now owns 112,038 shares of the health services provider’s stock valued at $2,414,000 after acquiring an additional 106,069 shares in the last quarter. Lecap Asset Management Ltd. bought a new stake in shares of Teladoc Health during the 4th quarter valued at about $1,530,000. Finally, Trexquant Investment LP purchased a new position in shares of Teladoc Health during the third quarter worth about $1,174,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

TDOC has been the subject of a number of research reports. Oppenheimer cut their price target on shares of Teladoc Health from $26.00 to $21.00 and set an “outperform” rating for the company in a research note on Friday, April 26th. TD Cowen reduced their target price on Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a research note on Friday, April 26th. Canaccord Genuity Group dropped their price target on Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a research note on Friday, April 26th. Wells Fargo & Company reduced their price objective on Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Monday, April 29th. Finally, SVB Leerink assumed coverage on Teladoc Health in a research report on Monday, February 26th. They issued a “market perform” rating and a $17.00 target price for the company. Twelve equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $18.73.

Insider Activity at Teladoc Health

In related news, insider Laizer Kornwasser sold 10,411 shares of Teladoc Health stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $132,115.59. Following the sale, the insider now owns 86,070 shares in the company, valued at $1,092,228.30. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, COO Michael Willem Waters sold 5,793 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the transaction, the chief operating officer now owns 64,881 shares in the company, valued at approximately $823,339.89. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Laizer Kornwasser sold 10,411 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the completion of the sale, the insider now directly owns 86,070 shares in the company, valued at $1,092,228.30. The disclosure for this sale can be found here. Insiders sold a total of 138,368 shares of company stock worth $1,989,227 over the last quarter. 0.95% of the stock is owned by corporate insiders.

Teladoc Health Price Performance

TDOC stock opened at $12.19 on Thursday. The stock has a market capitalization of $2.07 billion, a price-to-earnings ratio of -8.65 and a beta of 0.97. The firm’s 50-day moving average price is $14.26 and its two-hundred day moving average price is $17.39. The company has a current ratio of 3.82, a quick ratio of 3.74 and a debt-to-equity ratio of 0.67. Teladoc Health, Inc. has a 12-month low of $12.17 and a 12-month high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same quarter in the prior year, the firm earned ($0.37) EPS. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. As a group, equities analysts predict that Teladoc Health, Inc. will post -1.04 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.